Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

NASDAQTechnologySoftware - Application

Previous close

$19.71

+$0.13 · +0.66%

Aug 21, 4:00 PM ET

SDGR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

47

Fair Value

Momentum

54

Neutral

Sentiment

51

Mixed

Risk resilience

39

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Industry
Software - Application
Sector
Technology
Headquarters
US
CEO
Ramy Farid
Listed since
Feb 5, 2020
Employees
850

Market position

Day range

Current $19.71

52-week range

Current $19.71

Open
$19.825
Previous close
$19.58
Volume
1.1M
0.81× average
Average volume
1.35M
Average daily volume
Market cap
1.47B USD
Beta
1.66
Market reference 1
50-day average
$16.3798
+20.33% above average
200-day average
$15.0158
+31.26% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-26.64×
P/B (TTM)
4.48×
P/S (TTM)
5.69×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
56.87%
Operating margin
-59.24%
Net margin
-20.98%

Financial health

Debt / equity
0.33×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends82%15%-51%-117%Gross margin, FY2021: 47.57%Gross margin, FY2022: 55.83%Gross margin, FY2023: 64.93%Gross margin, FY2024: 63.64%Gross margin, FY2025: 55.74%Operating margin, FY2021: -80.80%Operating margin, FY2022: -81.13%Operating margin, FY2023: -81.90%Operating margin, FY2024: -100.85%Operating margin, FY2025: -65.23%Net margin, FY2021: -72.78%Net margin, FY2022: -82.44%Net margin, FY2023: 18.79%Net margin, FY2024: -90.16%Net margin, FY2025: -40.36%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 47.57%. Gross margin FY2022 55.83%. Gross margin FY2023 64.93%. Gross margin FY2024 63.64%. Gross margin FY2025 55.74%. Operating margin FY2021 -80.80%. Operating margin FY2022 -81.13%. Operating margin FY2023 -81.90%. Operating margin FY2024 -100.85%. Operating margin FY2025 -65.23%. Net margin FY2021 -72.78%. Net margin FY2022 -82.44%. Net margin FY2023 18.79%. Net margin FY2024 -90.16%. Net margin FY2025 -40.36%.

Income trends

Revenue

255.87M USD+23.29%

Operating income

−166.9M USD+20.26%

Net income

−103.27M USD+44.81%
Income trends across reported periods302.39M USD116.32M USD−69.75M USD−255.81M USDRevenue, FY2021: 137.93M USDRevenue, FY2022: 180.96M USDRevenue, FY2023: 216.67M USDRevenue, FY2024: 207.54M USDRevenue, FY2025: 255.87M USDOperating income, FY2021: −111.44M USDOperating income, FY2022: −146.82M USDOperating income, FY2023: −177.45M USDOperating income, FY2024: −209.3M USDOperating income, FY2025: −166.9M USDNet income, FY2021: −100.39M USDNet income, FY2022: −149.19M USDNet income, FY2023: 40.72M USDNet income, FY2024: −187.12M USDNet income, FY2025: −103.27M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 137.93M USD. Revenue FY2022 180.96M USD. Revenue FY2023 216.67M USD. Revenue FY2024 207.54M USD. Revenue FY2025 255.87M USD. Operating income FY2021 −111.44M USD. Operating income FY2022 −146.82M USD. Operating income FY2023 −177.45M USD. Operating income FY2024 −209.3M USD. Operating income FY2025 −166.9M USD. Net income FY2021 −100.39M USD. Net income FY2022 −149.19M USD. Net income FY2023 40.72M USD. Net income FY2024 −187.12M USD. Net income FY2025 −103.27M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue255.87M USD207.54M USD216.67M USD180.96M USD137.93M USD
Cost of goods sold113.26M USD75.46M USD75.97M USD79.93M USD72.31M USD
Gross profit142.61M USD132.08M USD140.69M USD101.02M USD65.62M USD
Research and development173.14M USD201.79M USD181.77M USD126.37M USD90.9M USD
Selling, general, and administrative136.37M USD139.59M USD136.37M USD121.47M USD86.16M USD
Operating expenses309.51M USD341.38M USD318.14M USD247.84M USD177.06M USD
Interest income3.95M USD1.06M USD
Interest expense3K USD
Depreciation and amortization6.02M USD6.16M USD5.55M USD4.34M USD2.85M USD
Operating income−166.9M USD−209.3M USD−177.45M USD−146.82M USD−111.44M USD
Net income−103.27M USD−187.12M USD40.72M USD−149.19M USD−100.39M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

12 ratings
Strong buy00%
Buy867%
Hold433%
Sell00%
Strong sell00%

SDGR peers

ETFs holding SDGR

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SDGR

research.disclaimer